Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BILB 1941 ZW in Chronic Hepatitis C Genotype 1
NCT02254707Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2004
- Primary completion
- Apr 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of BILB 1941 ZW in hepatitis C (HCV), sponsored by Boehringer Ingelheim. Started Jul 2004; status: completed.
02
Drugs
BILB 1941 ZW
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02254707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02254707.